ERAS

Erasca Inc (ERAS)

US
$ 1.586.04%

Price Chart

Key Statistics

Market Cap
$ 393.77M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
1.3M
52W High
$ 3.45
52W Low
$ 1.01
Dividend Yield
0.00%
Beta
1.13

Technicals

50-Day MA
1.3661
200-Day MA
2.2529
52 Week High
3.45
52 Week Low
1.01

About ERAS

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Employees
103
Headquarters
San Diego, CA
CEO
Dr. Jonathan E. Lim M.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg